CLiC Poll: Chemo-Immunotherapy Firstline for CLL
Excluding patients with del(17p)/TP53 mutation, which patients should be receiving chemo-immunotherapy firstline for CLL today?
Submit
This form was created inside of Sosido.com. Report Abuse - Terms of Service